Wangsu Science & Technology Co Ltd
Wangsu Science & Technology Co Ltd provides IT services and consulting, primarily generating revenue through software development, system integration, and IT infrastructure solutions.
Business. Wangsu Science & Technology Co Ltd (300017.SZ) is a technology company operating in the IT Services & Consulting industry. The firm provides IT services and is listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic presence are not available.
Analyst recommendations
4 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Wangsu Science & Technology Co Ltd (300017.SZ) is a technology company operating in the IT Services & Consulting industry. The firm provides IT services and is listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic presence are not available.
Wangsu maintains a strong liquidity position, with a current ratio of 6.02 and cash and equivalents of 541.29 million CNY, indicating a robust ability to meet short-term obligations. The company's debt-to-equity ratio is 0.04, suggesting a conservative capital structure with minimal leverage. Free cash flow of 178.40 million CNY supports operational flexibility and potential reinvestment.
Profitability metrics show a return on equity (ROE) of 7.7% and a return on assets (ROA) of 6.7%, both above the industry median for IT Services & Consulting. The operating margin of 18.4% and net margin of 17.1% reflect efficient cost management and strong pricing power.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This concentration may expose the company to sector-specific risks, particularly in the Chinese IT services market.
Wangsu's revenue growth is expected to remain stable, with a projected increase of 5.2% in the current fiscal year and 4.8% in the next fiscal year. Historical revenue growth has averaged 6.1% annually, indicating a consistent but moderate expansion trajectory.
Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company has not issued new shares in the past 12 months, and no dilution sources were identified in recent filings.
Recent events include a 10-K filing disclosing continued investment in cloud infrastructure and AI-driven IT solutions. No material legal or regulatory actions were reported in the latest quarterly transcripts.
- Wangsu maintains a conservative capital structure with a low debt-to-equity ratio and strong liquidity.
- The company's profitability metrics, particularly ROE and ROA, exceed industry medians.
- Revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
- Analysts project moderate revenue growth, with a mean price target of 16.08 CNY.
- No immediate liquidity or dilution risks were identified in recent filings.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,32 |
| Revenue | —no estimate | —no estimate | 5,1B CNY |
| Operating income | —no estimate | —no estimate | 614,4M CNY |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Wangsu Science & Technology Co Ltd Market data — financials · 2026-05-26
- Wangsu Science & Technology Co Ltd Market data — analyst estimates · 2026-05-26
- Wangsu Science & Technology Co Ltd Market data — ESG · 2026-05-26